U.S. market Closed. Opens in 2 days 1 hour 36 minutes

HUMAW | Humacyte, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
RevenueN/A1.56M1.26M1.49M6.19M
Cost of Revenue76.55M8.26M49.00K8.43M75.60M
Gross Profit-76.55M-6.69M1.21M-6.94M-69.42M
Operating Expenses23.50M84.58M81.21M64.60M16.27M
Selling, General & Admin20.39M22.88M21.13M12.01M16.27M
Research & Development76.55M63.26M61.34M54.08M75.60M
Other Operating Expenses-73.44M-1.56M-1.26M-1.49MN/A
Operating Income-100.05M-84.58M-81.21M-64.60M-85.69M
Other Expenses / Income-10.73M72.61M54.73M-1.92M269.00K
Before Tax Income-110.78M-11.96M-26.48M-66.52M-85.42M
Income Tax Expenses3.11M-76.18M-64.01M2.20MN/A
Net Income-110.78M64.22M37.54M-68.73M-85.42M
Interest Expenses-6.60M6.20M4.35M2.20M2.30M
Basic Shares Outstanding103.42M103.05M39.97M5.82M20.12M
Diluted Shares Outstanding103.42M103.05M39.97M5.82M20.12M
EBITDA-89.22M-160.34M-136.98M-55.97M-78.94M
EBITDA Margin0.00%-10,245.69%-10,845.61%-3,753.92%-1,275.93%
EBIT-114.27M-5.76M-22.13M-64.32M-83.12M
EBIT Margin0.00%-368.37%-1,752.10%-4,314.02%-1,343.53%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙